BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 17412583)

  • 1. Synthesis and biological evaluation of diamine-based histamine H3 antagonists with serotonin reuptake inhibitor activity.
    Stocking EM; Miller JM; Barbier AJ; Wilson SJ; Boggs JD; McAllister HM; Wu J; Lovenberg TW; Carruthers NI; Wolin RL
    Bioorg Med Chem Lett; 2007 Jun; 17(11):3130-5. PubMed ID: 17412583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploration of structure-activity relationships for dual serotonin transporter reuptake inhibitors-histamine H3 receptor antagonists.
    Stocking EM; Letavic MA; Bonaventure P; Carruthers NI
    Curr Top Med Chem; 2010; 10(5):596-616. PubMed ID: 20166942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel tetrahydroisoquinolines are histamine H3 antagonists and serotonin reuptake inhibitors.
    Letavic MA; Keith JM; Jablonowski JA; Stocking EM; Gomez LA; Ly KS; Miller JM; Barbier AJ; Bonaventure P; Boggs JD; Wilson SJ; Miller KL; Lord B; McAllister HM; Tognarelli DJ; Wu J; Abad MC; Schubert C; Lovenberg TW; Carruthers NI
    Bioorg Med Chem Lett; 2007 Feb; 17(4):1047-51. PubMed ID: 17127059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel naphthyridines are histamine H3 antagonists and serotonin reuptake transporter inhibitors.
    Letavic MA; Keith JM; Ly KS; Barbier AJ; Boggs JD; Wilson SJ; Lord B; Lovenberg TW; Carruthers NI
    Bioorg Med Chem Lett; 2007 May; 17(9):2566-9. PubMed ID: 17307358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benzylamine histamine H(3) antagonists and serotonin reuptake inhibitors.
    Letavic MA; Stocking EM; Barbier AJ; Bonaventure P; Boggs JD; Lord B; Miller KL; Wilson SJ; Carruthers NI
    Bioorg Med Chem Lett; 2007 Sep; 17(17):4799-803. PubMed ID: 17616397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyrrolidino-tetrahydroisoquinolines as potent dual H3 antagonist and serotonin transporter inhibitors.
    Keith JM; Gomez LA; Wolin RL; Barbier AJ; Wilson SJ; Boggs JD; Mazur C; Fraser IC; Lord B; Aluisio L; Lovenberg TW; Carruthers NI
    Bioorg Med Chem Lett; 2007 May; 17(9):2603-7. PubMed ID: 17317177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual serotonin transporter inhibitor/histamine H3 antagonists: development of rigidified H3 pharmacophores.
    Keith JM; Barbier AJ; Wilson SJ; Miller K; Boggs JD; Fraser IC; Mazur C; Lovenberg TW; Carruthers NI
    Bioorg Med Chem Lett; 2007 Oct; 17(19):5325-9. PubMed ID: 17765543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analogues and derivatives of ciproxifan, a novel prototype for generating potent histamine H3-receptor antagonists.
    Stark H; Ligneau X; Sadek B; Ganellin CR; Arrang JM; Schwartz JC; Schunack W
    Bioorg Med Chem Lett; 2000 Oct; 10(20):2379-82. PubMed ID: 11055360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel histamine H3 receptor antagonists based on the 4-[(1H-imidazol-4-yl)methyl]piperidine scaffold.
    Vaccaro WD; Sher R; Berlin M; Shih NY; Aslanian R; Schwerdt JH; McCormick KD; Piwinski JJ; West RE; Anthes JC; Williams SM; Wu RL; She HS; Rivelli MA; Mutter JC; Corboz MR; Hey JA; Favreau L
    Bioorg Med Chem Lett; 2006 Jan; 16(2):395-9. PubMed ID: 16246552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 3: 5-Substituted 3-phenyl-1,2,4-oxadiazoles as potent antagonists.
    Gfesser GA; Zhang H; Dinges J; Fox GB; Pan JB; Esbenshade TA; Yao BB; Witte D; Miller TR; Kang CH; Krueger KM; Bennani YL; Hancock AA; Faghih R
    Bioorg Med Chem Lett; 2004 Feb; 14(3):673-6. PubMed ID: 14741266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1-alkyl-4-acylpiperazines as a new class of imidazole-free histamine H(3) receptor antagonists.
    Zaragoza F; Stephensen H; Knudsen SM; Pridal L; Wulff BS; Rimvall K
    J Med Chem; 2004 May; 47(11):2833-8. PubMed ID: 15139761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of CYP450 inhibition in the 4-[(1H-imidazol-4-yl)methyl]piperidine series of histamine H3 receptor antagonists.
    Berlin M; Ting PC; Vaccaro WD; Aslanian R; McCormick KD; Lee JF; Albanese MM; Mutahi MW; Piwinski JJ; Shih NY; Duguma L; Solomon DM; Zhou W; Sher R; Favreau L; Bryant M; Korfmacher WA; Nardo C; West RE; Anthes JC; Williams SM; Wu RL; Susan She H; Rivelli MA; Corboz MR; Hey JA
    Bioorg Med Chem Lett; 2006 Feb; 16(4):989-94. PubMed ID: 16297617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel H3 receptor antagonists. Sulfonamide homologs of histamine.
    Wolin R; Connolly M; Afonso A; Hey JA; She H; Rivelli MA; Willams SM; West RE
    Bioorg Med Chem Lett; 1998 Aug; 8(16):2157-62. PubMed ID: 9873505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2-(4-alkylpiperazin-1-yl)quinolines as a new class of imidazole-free histamine H3 receptor antagonists.
    Zaragoza F; Stephensen H; Peschke B; Rimvall K
    J Med Chem; 2005 Jan; 48(1):306-11. PubMed ID: 15634025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ureas with histamine H3-antagonist receptor activity--a new scaffold discovered by lead-hopping from cinnamic acid amides.
    Lau JF; Jeppesen CB; Rimvall K; Hohlweg R
    Bioorg Med Chem Lett; 2006 Oct; 16(20):5303-8. PubMed ID: 16908150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, biological evaluation, and molecular docking of novel flavones as H
    Wen G; Liu Q; Hu H; Wang D; Wu S
    Chem Biol Drug Des; 2017 Oct; 90(4):580-589. PubMed ID: 28328173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 4-Chlorobenzyl sulfonamide and sulfamide derivatives of histamine homologues: the design of potent histamine H3 receptor antagonists.
    Tozer MJ; Buck IM; Cooke T; Kalindjian SB; McDonald IM; Pether MJ; Steel KI
    Bioorg Med Chem Lett; 1999 Nov; 9(21):3103-8. PubMed ID: 10560733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. General construction pattern of histamine H3-receptor antagonists: change of a paradigm.
    Stark H; Ligneau X; Arrang JM; Schwartz JC; Schunack W
    Bioorg Med Chem Lett; 1998 Aug; 8(15):2011-6. PubMed ID: 9873477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new class of histamine H(3)-receptor antagonists: synthesis and structure-activity relationships of 7,8,9,10-tetrahydro-6H-cyclohepta[b]quinolines.
    Turner SC; Esbenshade TA; Bennani YL; Hancock AA
    Bioorg Med Chem Lett; 2003 Jul; 13(13):2131-5. PubMed ID: 12798320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A scalable synthesis of a histamine H3 receptor antagonist.
    Mani NS; Jablonowski JA; Jones TK
    J Org Chem; 2004 Nov; 69(23):8115-7. PubMed ID: 15527300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.